<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Welch BM</submitter><funding>NIEHS NIH HHS</funding><funding>NIH HHS</funding><pagination>895-905</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9274448</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>176(9)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Phthalate exposure is widespread among pregnant women and may be a risk factor for preterm birth.&lt;h4>Objective&lt;/h4>To investigate the prospective association between urinary biomarkers of phthalates in pregnancy and preterm birth among individuals living in the US.&lt;h4>Design, setting, and participants&lt;/h4>Individual-level data were pooled from 16 preconception and pregnancy studies conducted in the US. Pregnant individuals who delivered between 1983 and 2018 and provided 1 or more urine samples during pregnancy were included.&lt;h4>Exposures&lt;/h4>Urinary phthalate metabolites were quantified as biomarkers of phthalate exposure. Concentrations of 11 phthalate metabolites were standardized for urine dilution and mean repeated measurements across pregnancy were calculated.&lt;h4>M</pubmed_abstract><journal>JAMA pediatrics</journal><pubmed_title>Associations Between Prenatal Urinary Biomarkers of Phthalate Exposure and Preterm Birth: A Pooled Study of 16 US Cohorts.</pubmed_title><pmcid>PMC9274448</pmcid><funding_grant_id>P01 ES009605</funding_grant_id><funding_grant_id>L40 ES032257</funding_grant_id><funding_grant_id>U24 ES028529</funding_grant_id><funding_grant_id>T32 ES007018</funding_grant_id><funding_grant_id>P30 ES010126</funding_grant_id><funding_grant_id>U24 ES028533</funding_grant_id><funding_grant_id>UH3 OD023251</funding_grant_id><funding_grant_id>P30 ES017885</funding_grant_id><funding_grant_id>R01 ES031591</funding_grant_id><funding_grant_id>P42 ES017198</funding_grant_id><funding_grant_id>R01 ES030078</funding_grant_id><funding_grant_id>P30 ES006096</funding_grant_id><funding_grant_id>P30 ES023513</funding_grant_id><funding_grant_id>R24 ES028533</funding_grant_id><pubmed_authors>O'Brien KM</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Newman RB</pubmed_authors><pubmed_authors>Alshawabkeh AN</pubmed_authors><pubmed_authors>Rauh VA</pubmed_authors><pubmed_authors>Drobnis EZ</pubmed_authors><pubmed_authors>Pooled Phthalate Exposure and Preterm Birth Study Group</pubmed_authors><pubmed_authors>Watkins DJ</pubmed_authors><pubmed_authors>James-Todd T</pubmed_authors><pubmed_authors>Dabelea D</pubmed_authors><pubmed_authors>Messerlian C</pubmed_authors><pubmed_authors>Christenbury KE</pubmed_authors><pubmed_authors>Jukic AMZ</pubmed_authors><pubmed_authors>Weinberg CR</pubmed_authors><pubmed_authors>Cordero JF</pubmed_authors><pubmed_authors>Binder AM</pubmed_authors><pubmed_authors>Swan SH</pubmed_authors><pubmed_authors>Schmidt RJ</pubmed_authors><pubmed_authors>Welch BM</pubmed_authors><pubmed_authors>Factor-Litvak P</pubmed_authors><pubmed_authors>Hauser R</pubmed_authors><pubmed_authors>Eskenazi B</pubmed_authors><pubmed_authors>Wenzel AG</pubmed_authors><pubmed_authors>Bradman A</pubmed_authors><pubmed_authors>Barrett ES</pubmed_authors><pubmed_authors>Buckley JP</pubmed_authors><pubmed_authors>Calafat AM</pubmed_authors><pubmed_authors>Harley KG</pubmed_authors><pubmed_authors>Sparks AE</pubmed_authors><pubmed_authors>Rich DQ</pubmed_authors><pubmed_authors>Hertz-Picciotto I</pubmed_authors><pubmed_authors>Nguyen RHN</pubmed_authors><pubmed_authors>Aalborg J</pubmed_authors><pubmed_authors>Padmanabhan V</pubmed_authors><pubmed_authors>Starling AP</pubmed_authors><pubmed_authors>Keil AP</pubmed_authors><pubmed_authors>Ferguson KK</pubmed_authors><pubmed_authors>Weinberger B</pubmed_authors><pubmed_authors>Engel SM</pubmed_authors><pubmed_authors>Lanphear BP</pubmed_authors><pubmed_authors>Bush NR</pubmed_authors><pubmed_authors>Braun JM</pubmed_authors><pubmed_authors>Zota AR</pubmed_authors><pubmed_authors>Bloom MS</pubmed_authors><pubmed_authors>Holland N</pubmed_authors><pubmed_authors>Michels KB</pubmed_authors><pubmed_authors>Baird DD</pubmed_authors><pubmed_authors>Sathyanarayana S</pubmed_authors><pubmed_authors>McElrath TF</pubmed_authors><pubmed_authors>Meeker JD</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Yolton K</pubmed_authors><pubmed_authors>Wilcox AJ</pubmed_authors><pubmed_authors>Cantonwine DE</pubmed_authors><pubmed_authors>Herbstman JB</pubmed_authors><pubmed_authors>Rosen EM</pubmed_authors><pubmed_authors>Redmon JB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Associations Between Prenatal Urinary Biomarkers of Phthalate Exposure and Preterm Birth: A Pooled Study of 16 US Cohorts.</name><description>&lt;h4>Importance&lt;/h4>Phthalate exposure is widespread among pregnant women and may be a risk factor for preterm birth.&lt;h4>Objective&lt;/h4>To investigate the prospective association between urinary biomarkers of phthalates in pregnancy and preterm birth among individuals living in the US.&lt;h4>Design, setting, and participants&lt;/h4>Individual-level data were pooled from 16 preconception and pregnancy studies conducted in the US. Pregnant individuals who delivered between 1983 and 2018 and provided 1 or more urine samples during pregnancy were included.&lt;h4>Exposures&lt;/h4>Urinary phthalate metabolites were quantified as biomarkers of phthalate exposure. Concentrations of 11 phthalate metabolites were standardized for urine dilution and mean repeated measurements across pregnancy were calculated.&lt;h4>M</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-07T17:54:05.963Z</modification><creation>2025-04-05T20:30:47.018Z</creation></dates><accession>S-EPMC9274448</accession><cross_references><pubmed>35816333</pubmed><doi>10.1001/jamapediatrics.2022.2252</doi></cross_references></HashMap>